Yanglin Chen – Trademark Portfolio

Entity Type: 01

Yanglin Chen holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 12 (Vehicles) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include COVNBXN. The owner is based in Changsha, Hunan.

Room 1905, 19th Floor, Building D3, Phase II, China Electronics Software Park, No. 18, Jianshan Road, Lugu Street, Changsha High-tech Development Zone

Changsha, Hunan 410000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

COVNBXN
COVNBXN
Registered 2025
COVNBXN
COVNBXN
Abandoned 2025

Trademark Classifications

Yanglin Chen's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

12
Vehicles (1 filing)

Vehicles; apparatus for locomotion by land, air or water

Frequently Asked Questions

How many trademarks does Yanglin Chen have?

Yanglin Chen has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Yanglin Chen file in?

Yanglin Chen files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 12 (Vehicles). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Yanglin Chen's most well-known trademarks?

Yanglin Chen's registered trademark portfolio includes well-known marks such as COVNBXN. These are among 1 currently registered trademark in the portfolio.

What is Yanglin Chen's trademark registration success rate?

Yanglin Chen has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.